Ausgabe 2/2024
Inhalt (8 Artikel)
Potential of Artificial Intelligence to Accelerate Drug Development for Rare Diseases
- Leading Article
Giulio Napolitano, Canan Has, Anne Schwerk, Jui-Hung Yuan, Carsten Ullrich
Why Oncology Global Safety Teams Should Develop the Safety Section of the Study’s Target Product Profile (TPP)
- Current Opinion
Michael E. Kieffer
Decentralisation in Clinical Trials and Patient Centricity: Benefits and Challenges
- Review Article
Shubhadeep D. Sinha, Sreenivasa Chary Sriramadasu, Ruby Raphael, Sudeshna Roy
Emergency Approval Mechanisms for Human Vaccines in India
- Review Article
Nidhi Mehrotra, Padmavati Manchikanti
Meaningful Within-Patient Change in Subjective Total Sleep Time in Patients with Insomnia Disorder: An Analysis of the Sleep Diary Questionnaire Using Data from Open-Label and Phase III Clinical Trials
- Open Access
- Original Research Article
Andrea Phillips-Beyer, Ariane K. Kawata, Leah Kleinman, Dalma Seboek Kinter, Bruno Flamion
Physician Awareness of the Safe Use of Cyproterone Acetate in Europe: A Survey on the Effectiveness of Additional Risk Minimization Measures
- Open Access
- Original Research Article
Carolyn Sweeney, Alicia Gilsenan, Brian Calingaert, Carsten Moeller, Gesa Schomakers, Alen Sok, Ruth Holzmann, Federica Pisa